STOCK TITAN

Asymmetry Point LP holds 610,000 shares of NexGel (NXGL) reporting 7.49% stake

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

NexGel, Inc. reports that Asymmetry Point LP beneficially owns 610,000 shares of Common Stock, representing 7.49% based on 8,143,133 shares outstanding as of November 12, 2025.

Asymmetry Point Capital LLC, as General Partner, and Mr. Aviv Argaman, as Fund Manager, are each disclosed as having sole voting and dispositive power over the 610,000 shares. Filers provided addresses and signed a joint filing agreement on March 12, 2026.

Positive

  • None.

Negative

  • None.

Insights

Large holder reports a 7.49% stake with voting control through affiliated entities.

The filing shows Asymmetry Point LP holds 610,000 shares, with Asymmetry Point Capital LLC as General Partner and Mr. Aviv Argaman as Fund Manager having sole voting and dispositive power. The November 12, 2025 share base (8,143,133) is cited for the percentage calculation.

Ownership above 5% is reportable under Schedule 13G; cash‑flow treatment and any planned transactions are not disclosed. Subsequent filings would detail changes in stake or transfers.






03/10/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: (1) Calculated based on 8,143,133 shares of Common Stock of NexGel, Inc. ("Issuer") as of November 12, 2025, as reported in the Form 10-Q for the quarter ended September 30, 2025, filed by the Issuer with the SEC on November 12, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) Asymmetry Point Capital LLC is the General Partner of Asymmetry Point LP and may be deemed to have sole voting and dispositive power over the 610,000 Shares held by Asymmetry Point LP. (2) Calculated based on 8,143,133 shares of Common Stock of NexGel, Inc. ("Issuer") as of November 12, 2025, as reported in the Form 10-Q for the quarter ended September 30, 2025, filed by the Issuer with the SEC on November 12, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) As the Fund Manager of Asymmetry Point Capital LLC (the "General Partner"), Mr. Aviv Argaman may be deemed to have sole voting and dispositive power over the 610,000 Shares held by Asymmetry Point LP. (2) Calculated based on 8,143,133 shares of Common Stock of NexGel, Inc. ("Issuer") as of November 12, 2025, as reported in the Form 10-Q for the quarter ended September 30, 2025, filed by the Issuer with the SEC on November 12, 2025.


SCHEDULE 13G



Asymmetry Point LP
Signature:/s/ Asymmetry Point LLC
Name/Title:General Partner
Date:03/12/2026
Signature:/s/ Mr. Aviv Argaman
Name/Title:President and Secretary
Date:03/12/2026
Asymmetry Point Capital LLC
Signature:/s/ Aviv Argaman
Name/Title:President and Secretary
Date:03/12/2026
Mr. Aviv Argaman
Signature:/s/ Mr. Aviv Argaman
Name/Title:AVIV ARGAMAN
Date:03/12/2026
Exhibit Information

Exhibit A - Joint Filing Agreement

FAQ

What stake does Asymmetry Point LP report in NXGL?

Asymmetry Point LP reports beneficial ownership of 610,000 shares, equal to 7.49% of NexGel's common stock, calculated using 8,143,133 shares outstanding as of November 12, 2025. The filing is a Schedule 13G.

Who holds voting and dispositive power over the reported NXGL shares?

The filing states Asymmetry Point Capital LLC is the General Partner and Mr. Aviv Argaman is the Fund Manager; both are disclosed as having sole voting and dispositive power over the 610,000 shares held by Asymmetry Point LP.

When was the ownership percentage for NXGL calculated?

The 7.49% ownership percentage was calculated using the issuer's share count of 8,143,133 common shares as of November 12, 2025, as reported in the company's Form 10-Q for the quarter ended September 30, 2025.

Does the filing disclose any purchases or sales of NXGL shares?

No purchase or sale transactions are disclosed in this Schedule 13G excerpt; it reports beneficial ownership and voting/dispositive power. The filing includes signatures dated March 12, 2026 but does not list transaction timing or cash‑flow details.
Nexgel Inc

NASDAQ:NXGL

View NXGL Stock Overview

NXGL Rankings

NXGL Latest News

NXGL Latest SEC Filings

NXGL Stock Data

7.75M
6.90M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
LANGHORNE